ENDOMETRIOSIS AND ENDOMETRIOID CANCER OF THE OVARIES: WHAT IS COMMON TO THEM?
https://doi.org/10.17650/1994-4098-2008-0-4-48-51
Abstract
About the Author
M. M. SonovaRussian Federation
References
1. Адамян Л.В., Кулаков В.И., Андреева Е.Н. Эндометриозы. Руководство для врачей. М.: Медицина, 2006.
2. Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Эндометриоидная болезнь. СПб.: Изд- во Н-Л, 2002.
3. Бурлев В.А., Шорохова М.А., Самойлова Т.Е. Современные принципы пато- генетического лечения эндометриоза. Репродуктивное здоровье женщины. Consil med 2007;9(6).
4. Bulun S.E., Zeitoun K.M., Sasano H. Molecular basis for treating endometriosis with aromatase inhibitors. Hum Reprod Update 2000;(5):413—8.
5. Bulun S.E., Simpson E.R., Word R.A Expression of the CYP19 gene and its prod- uct aromatase cytochrome P450 in human leiomyoma tissues and cells in culteere. J Clin Endocrinol Metab 1994;78:736—43.
6. Стрижаков А.М., Давыдов А.И. Эндометриоз. Клинические и теоретические аспекты. М.: Медицина, 1996.
7. Attar E., Bulun S.E. Aromatase and other steroidogenic genes in endometriosis: transla- tions aspects. Hum reprod 2006;12(1):49—56.
8. Краснопольская К.В., Калугина А.С. Первый опыт использования ингибито- ра ароматазы анастрозола в программе ЭКО при лечении бесплодия. Пробл ре- прод 2001;(6):24—8.
9. Ogava S., Kaku T., Kobayashi H. et al. Ovarion endometriosis associated with ovar- ion carcinoma: a clinicopathological and immunohystochemical study. Gynecol Oncol 2000;77:298—304.
10. Yoshikava H., Jimbo H., Okada S. et al. Prevalence of endometriosis in ovarian can- cer. Gynaecol Obstet Invest 2000;50(1):11—7.
11. Husslein H. Die medicamentose Behandlung der Endometiose. Arch Gynakol 1969;207(l—2):265—71.
12. Eifel P., Ross J., Hendrickson M. et al. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: Treatment comparisous. Cancer 1983;(52):1026—31.
13. Erzen M., Kovacic G. Relatoinship between endometriosis and ovarian cancer. Eur J Gynaecol Oncol 1998;19:553—5.
14. Stern R.C., Dash R., Bentley R.C. et al. Malignancy in endometriosis. Fegvancy and comparison of ovarian and extraovarion types. Int J Gynaecol Pathol 2001;20:133—9.
15. Barlow D.H. International congress on endometriosis with advanced endoscopic course. M., 1996. p. 43—7.
16. Sampson J.A. Perforating hemorrhagic (chocolate) cysts of the ovary. Arch Surg 1921;(3):245—323.
17. Sampson J.A. Benign and malignant endometrial implantats in the peritoneal cavity and their relation to certain ovarian tumors. Surg Gynecol Obstet 1924;38:287.
18. Sampson J.A. Heterotopic or misplaced endometrial tissue. Am J Obstet Gynecol 1925;10:649—64.
19. Johnston J.O. Aromatase inhibitors. Crit Rev Biochem Mol Biol 1998;33(5):375—405.
20. Simpson E., Rubin G., Clyne C. et al. Local estrogen biosynthesis in males and females. Endocr-Relat Cancer 1999;6:131—7.
21. Murphy A.A. Clinical aspects of endometriosis. Ann NY Acad Sci 2002;955:1—10.
22. Посисеева Л.В., Назарова А.О., Назаров С.Б. Значение оксида азота в патогенезе бесплодия при наружном генитальном эндометриозе. Акуш гинекол 1999;(6):37—40.
23. Wang Y., Sharma R.K., Falcone T. et al. Importance of reactive oxygen species in the peritoneal fluid of women with endometrio- sis or idiopathic infertility. Fertil Steril 1997;68:826—30.
24. Bulun S.E., Zeitoun K.M., Takayama K. et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr-Relat Cancer 1999;6:293—301.
25. Bulun S.E., Mahendroo M.S., Simpson E.R. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or deciduas. J Clin Endocrin Metab 1993;76:1458—63.
26. Huang J.C., Dawood M.Y., Wu K.K. Regulation of cyclooxygenase-2 gene in cul- tured endometrial stromal cells by sex steroids. Proc Am Soc Reprod Med Meeting S5, 1996 (abstr).
27. Noble L.S., Simpson E.R., Johns A. et al. Aromatase expression in endometriosis. J Clin Endocrin Metab 1996;81:174—9.
28. Noble L.S., Takayama K., Zeitoun K.M. et al. Prostaglandin E(2) stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrin Metab 1997;82:600—6.
29. Pagidas R., Falcone T., Hemmings R. et al. Comparison of reoperation for moderate (stage III) and severe (stage IV) endometriosis related infertility with in vitro fertilisation- embrio transfer. Fertil Steril 1996;6(4):791—5.
30. Ryan I.P., Taylor R.N. Endometriosis and infertility: new concepts. Obstet Gynecol Surv 1997;52:365—71.
31. Suratman R.B., Jacoeb T.Z., Cornain S. The use of immunohistochemical aromatase P450 in biopsied endometrium for detection of pelvic endometriosis in women with sus- pected endometriosis. Eur J Obstet Gynecol Reprod Biol 2005. S35.
32. Zeitoun K., Takayama K., Michael M.D. et al. Stimulation of aromatase P450 pro- moter (II) activity in endometriosis and itsinhibition in endometrium are regulated by competitive binding of SF-1 and COUP- TF to the same cis-acting element. J Mol Endocrinol 1999;13:239—53.
33. Bulun S.E., Zeitoun K.M., Takayama K., Sasano H. Estrogen biosinthesis in endometriosis: molecular basis and clinical relevance. J Mol Endocrinol 2000;25:35—42.
34. Ebert A.D., Bartley J., David M. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions — old answers? Eur J Obstet Gynecol Reprod Biol 2005;122 (2):144—50.
Review
For citations:
Sonova M.M. ENDOMETRIOSIS AND ENDOMETRIOID CANCER OF THE OVARIES: WHAT IS COMMON TO THEM? Tumors of female reproductive system. 2008;(4):48-51. (In Russ.) https://doi.org/10.17650/1994-4098-2008-0-4-48-51